Rapamycin formulations and methods of their use
US9387165B2 · kind B2 · utility
2Cited by
138References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 9, 2014 |
| Grant date | Jul 12, 2016 |
| Priority date | — |
| Expiry date | Mar 17, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are liquid rapamycin formulations. Described herein are methods of treating or preventing diseases or conditions, such as choroidal neovascularization, wet AMD and dry AMD, and preventing transition of dry AMD to wet AMD, using the liquid rapamycin formulations described herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.